These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6259678)

  • 21. Differential role of GABAA and GABAB receptors in two distinct output stations of the rat striatum: studies on the substantia nigra pars reticulata and the globus pallidus.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Neuroscience; 2010 Apr; 167(1):31-9. PubMed ID: 20132872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotoxic effect of intranigral injection of 1-methyl-4-phenylpyridinium on GABA-containing neurons and its relation to circling behavior.
    Jasso-López D; Tapia R
    J Neurochem; 1995 Feb; 64(2):794-801. PubMed ID: 7830073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.
    Gaudin DP; St-Pierre JA; Lavoie B; Bédard PJ
    Exp Neurol; 1994 May; 127(1):45-53. PubMed ID: 8200436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GABA(B) receptors modulate depolarization-stimulated [³H]glutamate release in slices of the pars reticulata of the rat substantia nigra.
    Cortés H; Paz F; Erlij D; Aceves J; Florán B
    Eur J Pharmacol; 2010 Dec; 649(1-3):161-7. PubMed ID: 20863782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
    Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
    Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity.
    Kerwin RW; Olpe HR; Schmutz M
    Br J Pharmacol; 1980; 71(2):545-51. PubMed ID: 6781578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic dopamine cell bodies in the rat.
    Dawbarn D; Pycock CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):100-4. PubMed ID: 6120471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
    Di Chiara G; Morelli M; Porceddu ML; Gessa GL
    Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of muscimol and picrotoxin injections into the cat substantia nigra.
    Wolfarth S; Kolasiewicz W; Sontag KH
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):54-60. PubMed ID: 6269004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate sensitization is modulated by valproate.
    Eckermann K; Beasley A; Yang P; Gaytan O; Swann A; Dafny N
    Life Sci; 2001 May; 69(1):47-57. PubMed ID: 11411804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological and behavioural correlations during the manipulations of GABA functions in the substantia nigra by n-dipropylacetate and picrotoxin.
    Scarnati E; Forchetti C; Ciancarelli G; Pacitti C; Agnoli A
    Pharmacol Res Commun; 1979 Oct; 11(9):817-24. PubMed ID: 119234
    [No Abstract]   [Full Text] [Related]  

  • 39. Valproate enhances GABA turnover in the substantia nigra.
    Löscher W
    Brain Res; 1989 Oct; 501(1):198-203. PubMed ID: 2508993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in apomorphine concentration in spinal cord and brain follow the time course of catalepsies induced by different treatments.
    Kolasiewicz W; Harasiewicz A; Melzacka M; Wolfarth S
    Exp Neurol; 1983 Jul; 81(1):195-209. PubMed ID: 6861947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.